Literature DB >> 24140645

Cytomegalovirus-seropositive children show inhibition of in vitro EBV infection that is associated with CD8+CD57+ T cell enrichment and IFN-γ.

Ebba Sohlberg1, Shanie Saghafian-Hedengren, Eahsan Rasul, Giovanna Marchini, Caroline Nilsson, Eva Klein, Noémi Nagy, Eva Sverremark-Ekström.   

Abstract

EBV, a human herpesvirus, is commonly acquired during childhood and persists latently in B cells. EBV seropositivity has been connected to immunomodulatory effects such as altered T and NK cell functional responses as well as protection against early IgE sensitization; however, owing to the asymptomatic presentation during childhood little is known regarding the infection process in children of different ages. In this study, we used mononuclear cells from cord blood and from 2- and 5-y-old EBV-naive children for in vitro EBV infection. We show that the degree of EBV-induced B cell activation and expansion differs between age groups and in particular in relationship to IFN-γ production capacity. EBV infection induced redistribution between B cell subsets with enrichment of IgD(+)CD27(+) cells (commonly referred to as non-switched memory) in infected cord blood cell cultures, and of IgD(-)CD27(+) cells (switched memory) in cell cultures from older children. We also related results to serostatus to CMV, a persistent herpesvirus that can affect differentiation status of T and NK cells. As compared with CMV(-) children, the EBV-induced enrichment of IgD(-)CD27(+) B cells was significantly reduced in infected cell cultures from CMV(+) children. This effect was associated with high levels of IFN-γ and frequencies of highly mature CD8(+)CD57(+) T cells in CMV(+) children. Our results demonstrate that both a child's age and serostatus to CMV will have an impact on EBV-induced B cell activation and expansion, and they point to the ability of viruses with immunomodulatory functions, such as CMV, to affect immune responses within the host system.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24140645      PMCID: PMC3831113          DOI: 10.4049/jimmunol.1301343

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

Review 1.  Heterologous immunity between viruses.

Authors:  Raymond M Welsh; Jenny W Che; Michael A Brehm; Liisa K Selin
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  TLR9 contributes to the recognition of EBV by primary monocytes and plasmacytoid dendritic cells.

Authors:  Stéphanie Fiola; David Gosselin; Kenzo Takada; Jean Gosselin
Journal:  J Immunol       Date:  2010-08-16       Impact factor: 5.422

3.  Epstein-Barr virus colonization of tonsillar and peripheral blood B-cell subsets in primary infection and persistence.

Authors:  Sridhar Chaganti; Emily M Heath; Wolfgang Bergler; Michael Kuo; Maike Buettner; Gerald Niedobitek; Alan B Rickinson; Andrew I Bell
Journal:  Blood       Date:  2009-04-07       Impact factor: 22.113

Review 4.  Redefining chronic viral infection.

Authors:  Herbert W Virgin; E John Wherry; Rafi Ahmed
Journal:  Cell       Date:  2009-07-10       Impact factor: 41.582

5.  Diagnosis of infectious mononucleosis caused by Epstein-Barr virus in infants.

Authors:  Sumitaka Dohno; Akihiko Maeda; Yoshihito Ishiura; Tetsuya Sato; Mikiya Fujieda; Hiroshi Wakiguchi
Journal:  Pediatr Int       Date:  2010-08       Impact factor: 1.524

6.  Subclass reactivity to Epstein-Barr virus capsid antigen in primary and reactivated EBV infections.

Authors:  A Linde; J Andersson; G Lundgren; B Wahren
Journal:  J Med Virol       Date:  1987-02       Impact factor: 2.327

Review 7.  Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes.

Authors:  George Klein; Eva Klein; Elena Kashuba
Journal:  Biochem Biophys Res Commun       Date:  2010-05-21       Impact factor: 3.575

8.  Early-life EBV infection protects against persistent IgE sensitization.

Authors:  Shanie Saghafian-Hedengren; Eva Sverremark-Ekström; Annika Linde; Gunnar Lilja; Caroline Nilsson
Journal:  J Allergy Clin Immunol       Date:  2009-12-05       Impact factor: 10.793

9.  Contribution of herpesvirus specific CD8 T cells to anti-viral T cell response in humans.

Authors:  Elena Sandalova; Diletta Laccabue; Carolina Boni; Anthony T Tan; Katja Fink; Eng Eong Ooi; Robert Chua; Bahar Shafaeddin Schreve; Carlo Ferrari; Antonio Bertoletti
Journal:  PLoS Pathog       Date:  2010-08-19       Impact factor: 6.823

10.  Flow cytometric and morphologic studies of HNK1+ (Leu 7+) lymphocytes in relation to cytomegalovirus carrier status.

Authors:  J W Gratama; H C Kluin-Nelemans; R A Langelaar; G J den Ottolander; T Stijnen; J D'Amaro; R Torensma; H J Tanke
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

View more
  11 in total

Review 1.  Known unknowns: how might the persistent herpesvirome shape immunity and aging?

Authors:  Janko Nikolich-Zugich; Felicia Goodrum; Kenneth Knox; Megan J Smithey
Journal:  Curr Opin Immunol       Date:  2017-08-04       Impact factor: 7.486

Review 2.  A constant companion: immune recognition and response to cytomegalovirus with aging and implications for immune fitness.

Authors:  Aisha Souquette; Justin Frere; Megan Smithey; Delphine Sauce; Paul G Thomas
Journal:  Geroscience       Date:  2017-06-24       Impact factor: 7.713

3.  Epstein-Barr virus coinfection in children boosts cytomegalovirus-induced differentiation of natural killer cells.

Authors:  Shanie Saghafian-Hedengren; Ebba Sohlberg; Jakob Theorell; Claudia Carvalho-Queiroz; Noémi Nagy; Jan-Olov Persson; Caroline Nilsson; Yenan T Bryceson; Eva Sverremark-Ekström
Journal:  J Virol       Date:  2013-10-02       Impact factor: 5.103

4.  Programmed death 1 is highly expressed on CD8+ CD57+ T cells in patients with stable multiple sclerosis and inhibits their cytotoxic response to Epstein-Barr virus.

Authors:  Maria T Cencioni; Roberta Magliozzi; Richard Nicholas; Rehiana Ali; Omar Malik; Richard Reynolds; Giovanna Borsellino; Luca Battistini; Paolo A Muraro
Journal:  Immunology       Date:  2017-09-21       Impact factor: 7.397

5.  Associations between EBV and CMV Seropositivity, Early Exposures, and Gut Microbiota in a Prospective Birth Cohort: A 10-Year Follow-up.

Authors:  Claudia Carvalho-Queiroz; Maria A Johansson; Jan-Olov Persson; Evelina Jörtsö; Torbjörn Kjerstadius; Caroline Nilsson; Shanie Saghafian-Hedengren; Eva Sverremark-Ekström
Journal:  Front Pediatr       Date:  2016-08-31       Impact factor: 3.418

Review 6.  Genetic Causes of Human NK Cell Deficiency and Their Effect on NK Cell Subsets.

Authors:  Emily M Mace; Jordan S Orange
Journal:  Front Immunol       Date:  2016-12-02       Impact factor: 7.561

7.  Epstein-Barr Virus, but Not Cytomegalovirus, Latency Accelerates the Decay of Childhood Measles and Rubella Vaccine Responses-A 10-Year Follow-up of a Swedish Birth Cohort.

Authors:  Gintare Lasaviciute; Sophia Björkander; Claudia Carvalho-Queiroz; Ida Hed Myrberg; Bianca Nussbaum; Caroline Nilsson; Mats Bemark; Anna Nilsson; Eva Sverremark-Ekström; Shanie Saghafian-Hedengren
Journal:  Front Immunol       Date:  2017-12-21       Impact factor: 7.561

8.  Asymptomatic Primary Infection with Epstein-Barr Virus: Observations on Young Adult Cases.

Authors:  Rachel J Abbott; Annette Pachnio; Isabela Pedroza-Pacheco; Alison M Leese; Jusnara Begum; Heather M Long; Debbie Croom-Carter; Andrea Stacey; Paul A H Moss; Andrew D Hislop; Persephone Borrow; Alan B Rickinson; Andrew I Bell
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

9.  Early T Cell Differentiation with Well-Maintained Function across the Adult Life Course in Sub-Saharan Africa.

Authors:  David J C Miles; Florence Shumba; Annette Pachnio; Jusnara Begum; Elizabeth L Corbett; Robert S Heyderman; Paul Moss
Journal:  J Immunol       Date:  2019-07-29       Impact factor: 5.422

10.  High-resolution phenotyping identifies NK cell subsets that distinguish healthy children from adults.

Authors:  Sanjana Mahapatra; Emily M Mace; Charles G Minard; Lisa R Forbes; Alexander Vargas-Hernandez; Teresa K Duryea; George Makedonas; Pinaki P Banerjee; William T Shearer; Jordan S Orange
Journal:  PLoS One       Date:  2017-08-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.